Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 26
Filtrar
Más filtros

Medicinas Complementárias
Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
ACS Appl Mater Interfaces ; 12(23): 25521-25533, 2020 Jun 10.
Artículo en Inglés | MEDLINE | ID: mdl-32425038

RESUMEN

Synthetic ion transporters have attracted tremendous attention for their therapeutic potential against various ion-transport-related diseases, including cancer. Inspired by the structure and biological activities of natural products, we synthesized a small series of squaramide and thiourea derivatives of quinine and investigated their ion transport activities. The involvement of a quinuclidine moiety for the cooperative interactions of Cl- and H+ ions with the thiourea or squaramide moiety resulted in an effectual transport of these ions across membranes. The interference of ionic equilibrium by the potent Cl- ion carrier selectively induced cancer cell death by endorsing caspase-arbitrated apoptosis. In vivo assessment of the potent ionophore showed an efficient reduction in tumor growth with negligible immunotoxicity to other organs.


Asunto(s)
Antineoplásicos/uso terapéutico , Proliferación Celular/efectos de los fármacos , Transporte Iónico/efectos de los fármacos , Neoplasias/tratamiento farmacológico , Quinina/análogos & derivados , Animales , Antineoplásicos/síntesis química , Antineoplásicos/farmacología , Apoptosis/efectos de los fármacos , Línea Celular Tumoral , Cloruros/metabolismo , Humanos , Ratones , Pruebas de Sensibilidad Microbiana , Protones , Quinina/farmacología , Quinina/uso terapéutico , Tiourea/análogos & derivados , Tiourea/farmacología , Tiourea/uso terapéutico , Ensayos Antitumor por Modelo de Xenoinjerto
2.
Neurochem Res ; 45(1): 16-33, 2020 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-31346893

RESUMEN

The release of [3H]dopamine ([3H]DA) and [3H]noradrenaline ([3H]NA) in acutely perfused rat striatal and cortical slice preparations was measured at 37 °C and 17 °C under ischemic conditions. The ischemia was simulated by the removal of oxygen and glucose from the Krebs solution. At 37 °C, resting release rates in response to ischemia were increased; in contrast, at 17 °C, resting release rates were significantly reduced, or resting release was completely prevented. The removal of extracellular Ca2+ further increased the release rates of [3H]DA and [3H]NA induced by ischemic conditions. This finding indicated that the Na+/Ca2+ exchanger (NCX), working in reverse in the absence of extracellular Ca2+, fails to trigger the influx of Ca2+ in exchange for Na+ and fails to counteract ischemia by further increasing the intracellular Na+ concentration ([Na+]i). KB-R7943, an inhibitor of NCX, significantly reduced the cytoplasmic resting release rate of catecholamines under ischemic conditions and under conditions where Ca2+ was removed. Hypothermia inhibited the excessive release of [3H]DA in response to ischemia, even in the absence of Ca2+. These findings further indicate that the NCX plays an important role in maintaining a high [Na+]i, a condition that may lead to the reversal of monoamine transporter functions; this effect consequently leads to the excessive cytoplasmic tonic release of monoamines and the reversal of the NCX. Using HPLC combined with scintillation spectrometry, hypothermia, which enhances the stimulation-evoked release of DA, was found to inhibit the efflux of toxic DA metabolites, such as 3,4-dihydroxyphenylacetaldehyde (DOPAL). In slices prepared from human cortical brain tissue removed during elective neurosurgery, the uptake and release values for [3H]NA did not differ from those measured at 37 °C in slices that were previously maintained under hypoxic conditions at 8 °C for 20 h. This result indicates that hypothermia preserves the functions of the transport and release mechanisms, even under hypoxic conditions. Oxidative stress (H2O2), a mediator of ischemic brain injury enhanced the striatal resting release of [3H]DA and its toxic metabolites (DOPAL, quinone). The study supports our earlier findings that during ischemia transmitters are released from the cytoplasm. In addition, the major findings of this study that hypothermia of brain slice preparations prevents the extracellular calcium concentration ([Ca2+]o)-independent non-vesicular transmitter release induced by ischemic insults, inhibiting Na+/Cl--dependent membrane transport of monoamines and their toxic metabolites into the extracellular space, where they can exert toxic effects.


Asunto(s)
Isquemia Encefálica/metabolismo , Catecolaminas/metabolismo , Líquido Extracelular/metabolismo , Hipotermia/metabolismo , Intercambiador de Sodio-Calcio/metabolismo , Accidente Cerebrovascular/metabolismo , Adulto , Anciano , Animales , Isquemia Encefálica/prevención & control , Catecolaminas/antagonistas & inhibidores , Líquido Extracelular/efectos de los fármacos , Lóbulo Frontal/efectos de los fármacos , Lóbulo Frontal/metabolismo , Humanos , Persona de Mediana Edad , Ratas , Ratas Wistar , Intercambiador de Sodio-Calcio/antagonistas & inhibidores , Accidente Cerebrovascular/terapia , Tiourea/análogos & derivados , Tiourea/farmacología , Tiourea/uso terapéutico
3.
Kidney Int ; 88(2): 311-20, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-25993324

RESUMEN

Inhibitors of kidney urea transporter (UT) proteins have potential use as salt-sparing diuretics ('urearetics') with a different mechanism of action than diuretics that target salt transporters. To study UT inhibition in rats, we screened about 10,000 drugs, natural products and urea analogs for inhibition of rat UT-A1. Drug and natural product screening found nicotine, sanguinarine and an indolcarbonylchromenone with IC50 of 10-20 µM. Urea analog screening found methylacetamide and dimethylthiourea (DMTU). DMTU fully and reversibly inhibited rat UT-A1 and UT-B by a noncompetitive mechanism with IC50 of 2-3 mM. Homology modeling and docking computations suggested DMTU binding sites on rat UT-A1. Following a single intraperitoneal injection of 500 mg/kg DMTU, peak plasma concentration was 9 mM with t1/2 of about 10 h, and a urine concentration of 20-40 mM. Rats chronically treated with DMTU had a sustained, reversible reduction in urine osmolality from 1800 to 600 mOsm, a 3-fold increase in urine output, and mild hypokalemia. DMTU did not impair urinary concentrating function in rats on a low protein diet. Compared to furosemide-treated rats, the DMTU-treated rats had greater diuresis and reduced urinary salt loss. In a model of syndrome of inappropriate antidiuretic hormone secretion, DMTU treatment prevented hyponatremia and water retention produced by water-loading in dDAVP-treated rats. Thus, our results establish a rat model of UT inhibition and demonstrate the diuretic efficacy of UT inhibition.


Asunto(s)
Diuresis/efectos de los fármacos , Proteínas de Transporte de Membrana/metabolismo , Cloruro de Sodio/orina , Tiourea/análogos & derivados , Animales , Sitios de Unión , Modelos Animales de Enfermedad , Diuréticos/farmacología , Perros , Evaluación Preclínica de Medicamentos , Femenino , Furosemida/farmacología , Hipopotasemia/inducido químicamente , Hiponatremia/etiología , Hiponatremia/prevención & control , Síndrome de Secreción Inadecuada de ADH/complicaciones , Síndrome de Secreción Inadecuada de ADH/tratamiento farmacológico , Concentración 50 Inhibidora , Células de Riñón Canino Madin Darby , Proteínas de Transporte de Membrana/química , Estructura Molecular , Concentración Osmolar , Ratas , Ratas Wistar , Tiourea/sangre , Tiourea/química , Tiourea/farmacología , Tiourea/uso terapéutico , Factores de Tiempo , Orina/química , Transportadores de Urea
4.
Neuromolecular Med ; 17(1): 58-70, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25582550

RESUMEN

We have previously reported that mild traumatic brain injury (mTBI) induced cognitive deficits as well as apoptotic changes in the brains of mice. Apoptosis may be caused by severe, prolonged accumulation of misfolded proteins, and protein aggregation in the endoplasmic reticulum (ER stress). In an additional study, we have reported that mTBI activated the pro-apoptotic arm of the integrated stress response (ISR). The main goal of the present study was to test the involvement of the adaptive eIF2α/ATF4 pathway in mTBI-affected brains. Head injury was induced with a noninvasive, closed-head weight drop (30 g) to ICR mice. Salubrinal, the selective phosphatase inhibitor of p-eIF2α, was injected immediately and 24 h after mTBI (1 mg/kg, ip). Y-maze and novel object recognition tests to assess spatial and visual memories, respectively, were conducted either 7 or 30 days post-trauma. Salubrinal administration significantly improved memory deficits following mTBI. Slaubrinal also prevented the elevation of degenerating neurons and the reduction of mature neurons in the cortex (as seen by immunofluorescent staining with Fluoro-Jade-B and NeuN antibodies, 72 h and 1 week post-mTBI, respectively). Western blot analysis revealed that salubrinal prevented the significant reduction in eIF2α and ATF4 phosphorylation in mTBI brains 72 h post-injury. Immunofluorescence staining revealed that although the reduction in p-eIF2α did not reach significance, salubrinal administration elevated it dramatically. Our results show that targeting the translational/adaptive arm of the ISR with salubrinal may serve as a therapeutic strategy for brain damage.


Asunto(s)
Lesiones Encefálicas/tratamiento farmacológico , Cinamatos/uso terapéutico , Fármacos Neuroprotectores/uso terapéutico , Tiourea/análogos & derivados , Factor de Transcripción Activador 4/fisiología , Animales , Apoptosis/efectos de los fármacos , Daño Encefálico Crónico/etiología , Daño Encefálico Crónico/prevención & control , Lesiones Encefálicas/complicaciones , Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/lesiones , Corteza Cerebral/patología , Trastornos del Conocimiento/etiología , Trastornos del Conocimiento/prevención & control , Evaluación Preclínica de Medicamentos , Estrés del Retículo Endoplásmico/efectos de los fármacos , Factor 2 Eucariótico de Iniciación/fisiología , Conducta Exploratoria/efectos de los fármacos , Hipocampo/efectos de los fármacos , Hipocampo/lesiones , Hipocampo/patología , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Ratones , Ratones Endogámicos ICR , Proteínas del Tejido Nervioso/fisiología , Neuronas/patología , Fosforilación/efectos de los fármacos , Procesamiento Proteico-Postraduccional/efectos de los fármacos , Reconocimiento en Psicología/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Tiourea/uso terapéutico , Heridas no Penetrantes/complicaciones , Heridas no Penetrantes/tratamiento farmacológico
5.
Neurosci Lett ; 580: 173-7, 2014 Sep 19.
Artículo en Inglés | MEDLINE | ID: mdl-25123443

RESUMEN

Remote areas connected to cortical infarcts, such as the thalamus, are affected by stroke due to delayed retrograde degeneration of afferent connections. This is temporally associated with the accumulation of ß-amyloid (Aß) and calcium. Here we tested a hypothesis that prevention of excessive Ca(2+) influx into the axoplasm via the reverse Na(+)/Ca(2+) exchanger (NCX) would provide axonal protection and eventually lessen the Aß and calcium load in the thalamus. We found that chronic treatment with a specific inhibitor of the reverse NCX, KB-R7943 (30mg/kg once daily, 27 days) after middle cerebral artery occlusion did not prevent atypical secondary pathology in the thalamus or improve functional outcome. The present data do not support a role for reverse NCX activity in the complex pathology within the thalamus after cerebral ischemia.


Asunto(s)
Péptidos beta-Amiloides/metabolismo , Ataque Isquémico Transitorio/tratamiento farmacológico , Fragmentos de Péptidos/metabolismo , Intercambiador de Sodio-Calcio/antagonistas & inhibidores , Tálamo/efectos de los fármacos , Tiourea/análogos & derivados , Animales , Calcio/metabolismo , Ataque Isquémico Transitorio/metabolismo , Ataque Isquémico Transitorio/fisiopatología , Masculino , Destreza Motora/efectos de los fármacos , Ratas Wistar , Tálamo/metabolismo , Tiourea/farmacología , Tiourea/uso terapéutico
6.
J Nephrol ; 26(5): 877-85, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23475466

RESUMEN

BACKGROUND: Intracellular Ca2+ overload is considered to be a key factor in contrast-induced acute kidney injury (CI-AKI). The Na+/Ca2+ exchanger (NCX) system is one of the main pathways of intracellular Ca2+ overload. We investigated the effects of KB-R7943, an inhibitor of the reverse mode of NCX, on CI-AKI in a rat model. METHOD: Rats were divided into control group, CI-AKI group and pretreatment groups (with KB-R7943 dose of 5 or 10 mg/kg). CI-AKI was induced by diatrizoate administration in rats with cholesterol-supplemented diet for 8 weeks. Renal function and renal hemodynamics were determined 1 day following contrast medium administration. Renal histopathology was observed by light microscope. Renal tubular apoptosis was examined by TUNEL. Renal endothelin-1 (ET-1) was measured by radioimmunoassay. Renal malondialdehyde (MDA) and catalase (CAT) were measured as oxidative markers. RESULTS: Levels of serum creatinine (Scr), renal ET-1, MDA and CAT, and resistance index (RI) of renal blood vessels increased significantly in CI-AKI rats. The increases in Scr and RI of renal blood vessels induced by diatrizoate were suppressed significantly and dose-dependently by pretreatment with KB-R7943. Histopathological and TUNEL results showed that the contrast medium-induced severe renal tubular necrosis and apoptosis were significantly and dose-dependently attenuated by KB-R7943. KB-R7943 significantly suppressed the increment of renal ET-1 content and MDA and CAT level induced by contrast medium administration. CONCLUSION: Activation of the reverse mode of NCX, followed by ET-1 overproduction and increased oxidative stress, seems to play an important role in the pathogenesis of CI-AKI. The inhibitor of the reverse mode of NCX, KB-R7943, has renoprotective effects on CI-AKI.


Asunto(s)
Lesión Renal Aguda/tratamiento farmacológico , Medios de Contraste/efectos adversos , Endotelina-1/metabolismo , Intercambiador de Sodio-Calcio/antagonistas & inhibidores , Tiourea/análogos & derivados , Lesión Renal Aguda/inducido químicamente , Lesión Renal Aguda/patología , Lesión Renal Aguda/fisiopatología , Animales , Apoptosis , Catalasa/análisis , Creatinina/sangre , Diatrizoato , Relación Dosis-Respuesta a Droga , Endotelina-1/análisis , Riñón/irrigación sanguínea , Riñón/efectos de los fármacos , Túbulos Renales/metabolismo , Túbulos Renales/patología , Masculino , Malondialdehído/análisis , Necrosis/tratamiento farmacológico , Ratas , Ratas Wistar , Tiourea/uso terapéutico , Resistencia Vascular
7.
Bioorg Med Chem Lett ; 19(12): 3238-42, 2009 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-19423344

RESUMEN

Novel 1-(2-aminopyrazin-3-yl)methyl-2-thioureas are described as inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2). These compounds demonstrate potent in vitro activity against the enzyme with IC(50) values as low as 15 nM, and suppress expression of TNFalpha in THP-1 cells and in vivo in an acute inflammation model in mice. The synthesis, structure-activity relationship (SAR), and biological evaluation of these compounds are discussed.


Asunto(s)
Péptidos y Proteínas de Señalización Intracelular/antagonistas & inhibidores , Proteínas Serina-Treonina Quinasas/antagonistas & inhibidores , Tiourea/química , Animales , Línea Celular Tumoral , Evaluación Preclínica de Medicamentos , Humanos , Inflamación/tratamiento farmacológico , Concentración 50 Inhibidora , Ratones , Inhibidores de Proteínas Quinasas/química , Inhibidores de Proteínas Quinasas/farmacología , Inhibidores de Proteínas Quinasas/uso terapéutico , Relación Estructura-Actividad , Tiourea/farmacología , Tiourea/uso terapéutico , Factor de Necrosis Tumoral alfa/efectos de los fármacos
8.
Pharmacol Ther ; 111(3): 808-35, 2006 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-16483666

RESUMEN

Sudden cardiac death resulting from ventricular tachyarrhythmias remains the leading cause of death in industrially developed countries, accounting for between 300,000 and 500,000 deaths each year in the United States. Yet, despite the enormity of this problem, the development of safe and effective anti-arrhythmic agents remains elusive. The identification of effective anti-arrhythmic agents is critically dependent upon the use of appropriate animal models of human disease. During the last 25 years, a canine model of sudden cardiac death has proven to be useful in both the identification of factors contributing to ventricular fibrillation (VF) and the evaluation of potential anti-arrhythmic therapies. The present review provides a detailed retrospective analysis of the data obtained with this model. Briefly, VF was reliably and reproducibly induced by the combination of acute myocardial ischemia at site distant from a previous myocardial infarction during submaximal exercise (to activate the autonomic nervous system). This exercise plus ischemia test identified 2 stable populations of dogs: those that development malignant arrhythmias (susceptible, n=303) and those that rarely developed even single premature ventricular activation (resistant, n=209). The susceptible animals exhibited an elevated sympathetic activation (due to an enhanced beta2-adrenoceptor responsiveness) and a subnormal parasympathetic regulation. Several interventions have proven to be particularly effective in preventing VF in the susceptible dogs; including calcium channel antagonists, left stellate ganglion disruption, ATP-sensitive potassium channel antagonists, beta-adrenoceptor antagonists, and non-pharmacological interventions (endurance exercise training and dietary omega-3 fatty acids).


Asunto(s)
Antiarrítmicos/uso terapéutico , Muerte Súbita Cardíaca/etiología , Fibrilación Ventricular/tratamiento farmacológico , Animales , Sistema Nervioso Autónomo/fisiología , Presión Sanguínea , Calcio/metabolismo , Modelos Animales de Enfermedad , Perros , Electrocardiografía , Ejercicio Físico , Aceites de Pescado/farmacología , Corazón/inervación , Frecuencia Cardíaca , Humanos , Sulfonamidas/uso terapéutico , Tiourea/análogos & derivados , Tiourea/uso terapéutico , Fibrilación Ventricular/etiología , Fibrilación Ventricular/fisiopatología
11.
Ann Thorac Surg ; 60(5): 1376-81, 1995 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-8526630

RESUMEN

BACKGROUND: Early allograft dysfunction remains a frequently encountered problem in clinical lung transplantation. Lung ischemia-reperfusion injury is associated with increased vascular permeability, which may be due in part to oxygen (O2) free radicals. However, it is not clear whether O2 free radicals are produced during ischemia under storage conditions in clinical lung transplantation. METHODS: Using an isolated ex vivo rabbit lung model, we studied the effects of preservation temperature on pulmonary capillary filtration coefficient (Kf) and lipid peroxidation in rabbit lungs inflated with 100% O2 after preservation with or without the O2 free radical scavenger dimethylthiourea. New Zealand white rabbits weighing 2.7 to 3.1 kg were intubated and ventilated with room air or 100% O2 (tidal volume = 25 mL). After heparinization and sternotomy, the pulmonary artery was flushed with low-potassium-dextran-1% glucose solution (200 mL). The heart-lung block was excised, submerged, and stored for 24 hours at 1 degree or 10 degrees C. After 24-hour preservation, the heart-lung block was suspended from a strain-gauge force transducer and ventilated with room air. The pulmonary artery cannula was connected to a reservoir of hetastarch solution. The lungs were flushed briefly with the hetastarch solution, and the reservoir was raised sequentially at 8-minute intervals to achieve 1.0 to 1.5 mm Hg increments in pulmonary artery pressure. Lung weight gain, airway pressure, pulmonary artery pressure, and left atrial pressure were measured continuously. The slope of steady-state lung weight gain was used to determine Kf (g.min-1.cm H2O-1 x 100 g-1 wet weight). RESULTS: Twenty-four-hour lung preservation at both 1 degree and 10 degrees C increased Kf. A similar increase in Kf was observed in lungs stored at 1 degree C while inflated with 100% O2. However, a significant increase in Kf was observed when lungs inflated with 100% O2 were stored at 10 degrees C. This increase in Kf was ameliorated by dimethylthiourea. Thiobarbituric acid-reactive substance levels were increased in lungs stored at 10 degrees C while inflated with 100% O2. This finding was eliminated by dimethylthiourea. CONCLUSIONS: These results indicate that free radical injury occurs during the ischemic phase when lungs are stored at moderate hypothermia while inflated with 100% O2.


Asunto(s)
Criopreservación/métodos , Depuradores de Radicales Libres/uso terapéutico , Trasplante de Pulmón , Pulmón/irrigación sanguínea , Preservación de Órganos/métodos , Daño por Reperfusión/prevención & control , Tiourea/análogos & derivados , Animales , Permeabilidad Capilar , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos , Peroxidación de Lípido/fisiología , Tamaño de los Órganos , Oxígeno/uso terapéutico , Conejos , Daño por Reperfusión/etiología , Daño por Reperfusión/patología , Temperatura , Sustancias Reactivas al Ácido Tiobarbitúrico/análisis , Tiourea/uso terapéutico
12.
Inflammation ; 19(2): 207-19, 1995 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-7601506

RESUMEN

A mouse model of hypersensitivity pneumonitis was generated by challenge with a thermophilic actinomycete. Oxygen radical scavengers were administered to challenged mice: vitamin E at 1000 units daily, polyethylene glycol-superoxide dismutase (SOD) at 500 units daily, polyethylene glycol-catalase at 10,000 units daily, 1,3,dimethyl-2-thiourea (DMTU) at 2 mg daily, and the biomimetic SOD, copper(II) [diisopropyl salicylate]2 (CuDIPS) at 1 mg daily. At three weeks after actinomycete challenge, a 10-fold increase in bronchoalveolar (BAL) cell number was observed. Treatments with catalase or DMTU were without effect on the BAL cell number in challenged mice. However, infusion of vitamin E was associated with an increased BAL cell influx (15-fold increase at two and three weeks). Similarly, treatment with PEG-SOD and CuDIPS resulted in an increase in cell number at two and three weeks. PEG-SOD or CuDIPS treatment resulted in a strong neutrophilia, whereas control challenged mice had a cellular influx mostly of macrophages and lymphocytes. Vitamin E treatment of challenged mice led to an increased T lymphocyte recruitment at two and three weeks. In vitro studies showed that actinomycete challenge was associated with an enhancement of alveolar macrophage O2- release, which was blocked by PEG-SOD, vitamin E, or DSC treatment but was unaffected by catalase or DMTU treatment. In control challenged mice, there was a 25-fold increase in the BAL albumin concentration at two weeks. PEG-SOD, vitamin E, or CuDIPS treatment all decreased the albumin concentration; the three modulators also diminished lung fibrosis at two or three weeks, as seen by a decrease in lung hydroxyproline and collagen synthesis by lung fibroblasts. Examination of sections from lungs of challenged animals showed evidence of cellular infiltrates around the bronchi and the blood vessels. Challenged mice given continuous infusions of vitamin E, SOD, or CuDIPS had lung histological scores that were significantly lower than control challenged mice or challenged mice treated with catalase or DMTU. Thus, therapies based on O2- scavenging or treatment with a general antioxidant such as vitamin E may hold some promise in the treatment of hypersensitivity pneumonitis.


Asunto(s)
Antioxidantes/uso terapéutico , Pulmón de Granjero/tratamiento farmacológico , Fibrosis Pulmonar/prevención & control , Animales , Antígenos Fúngicos/toxicidad , Antioxidantes/farmacología , Líquido del Lavado Bronquioalveolar/citología , Colágeno/metabolismo , Pulmón de Granjero/complicaciones , Pulmón de Granjero/inmunología , Pulmón de Granjero/microbiología , Fibroblastos/metabolismo , Fibroblastos/patología , Depuradores de Radicales Libres , Hidroxiprolina/metabolismo , Macrófagos Alveolares/efectos de los fármacos , Macrófagos Alveolares/metabolismo , Macrófagos Alveolares/patología , Ratones , Ratones Endogámicos C57BL , Micromonosporaceae/inmunología , Neutrófilos/patología , Fibrosis Pulmonar/etiología , Fibrosis Pulmonar/inmunología , Especies Reactivas de Oxígeno/metabolismo , Salicilatos/farmacología , Salicilatos/uso terapéutico , Organismos Libres de Patógenos Específicos , Superóxido Dismutasa/farmacología , Superóxido Dismutasa/uso terapéutico , Linfocitos T/patología , Tiourea/análogos & derivados , Tiourea/farmacología , Tiourea/uso terapéutico , Vitamina E/farmacología , Vitamina E/uso terapéutico
13.
Ophthalmic Res ; 27(3): 136-43, 1995.
Artículo en Inglés | MEDLINE | ID: mdl-8538990

RESUMEN

To ascertain the effectiveness of topical antioxidant therapy on acute corneal inflammation, we have studied the effectiveness of topical treatment with a saline solution and with antioxidants such as 0.2% superoxide dismutase and 0.5% dimethylthiourea (DMTU) in a controlled experimental study. The evolution of the inflammatory process was evaluated by a multimodel approach, including computer-assisted planimetry of the corneal ulcer and infiltrate, ultrasonic pachymetry, luminol-amplified chemiluminescence and the study of corneal transparency by direct spectral spectrophotometry transmittance. The experimental model was a corneal ulcer created by a 60-second application of 1 N sodium hydroxide. Topical treatment with DMTU was shown to significantly improve all parameters tested, while superoxide dismutase reduced only the corneal ulcers. Antioxidant topical therapy with DMTU was shown to be efficient in reducing the inflammatory reaction that occurs during acute corneal inflammation. This suggests that antioxidant therapy could be considered as a complementary treatment in the pharmacological modulation of acute corneal inflammation.


Asunto(s)
Antioxidantes/uso terapéutico , Úlcera de la Córnea/tratamiento farmacológico , Depuradores de Radicales Libres/uso terapéutico , Superóxido Dismutasa/uso terapéutico , Tiourea/análogos & derivados , Enfermedad Aguda , Administración Tópica , Animales , Quemaduras Químicas/etiología , Córnea/efectos de los fármacos , Córnea/fisiología , Úlcera de la Córnea/etiología , Úlcera de la Córnea/fisiopatología , Modelos Animales de Enfermedad , Quemaduras Oculares/inducido químicamente , Soluciones Oftálmicas , Conejos , Hidróxido de Sodio , Tiourea/uso terapéutico
14.
Am J Med Sci ; 308(5): 266-70, 1994 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-7977444

RESUMEN

The synergistic effects of combining fish oil (FO) diet, which reduces thromboxane A production, with the free radical scavenger, dimethylthiourea (DMTU), were evaluated in acute adriamycin nephrosis, because proteinuria in adriamycin nephrosis is mediated by increased renal thromboxane A and free radical production. The effects of combined evening primrose oil (EPO) and DMTU were compared with the DMTU + FO combination because EPO increases prostaglandin E but not thromboxane A. After 7, 14, and 21 days, proteinuria was significantly (p < 0.05) reduced in rats receiving either DMTU + corn oil (CO) or DMTU + FO compared with untreated control rats. However, after 21 days, rats receiving DMTU + FO had significantly reduced urine protein excretion compared with those receiving DMTU + CO (103.9 +/- 20 mg daily vs 351.8 +/- 29.8 mg daily; P < 0.05). In contrast to FO, rats receiving EPO + DMTU had similar urine protein excretion to rats receiving DMTU + CO after 21 days (170.2 +/- 20.34 mg daily vs 179.45 +/- 26.38 mg daily). The mean serum cholesterol concentration was significantly (P < 0.01) reduced in rats receiving DMTU + FO (195.2 +/- 23.8 mg/dL) compared with DMTU + CO (377.9 +/- 28.5 mg/dL). Serum triglyceride levels also were significantly (P < 0.01) reduced in rats receiving DMTU + FO (52.5 +/- 26.4 mg/dL) compared with DMTU + CO (100.5 +/- 36.9 mg/dL). No significant differences in serum cholesterol concentrations or triglycerides occurred between rats receiving DMTU + CO and DMTU + EPO. Renal glutathione content was significantly (P < 0.05) increased by 23% in normal rats receiving FO diet and by 34% in rats receiving combined DMTU + FO compared with CO alone.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Grasas de la Dieta/uso terapéutico , Doxorrubicina/toxicidad , Aceites de Pescado/uso terapéutico , Riñón/efectos de los fármacos , Nefrosis/terapia , Tiourea/análogos & derivados , Animales , Colesterol/sangre , Aceite de Maíz , Quimioterapia Combinada , Ácidos Grasos Esenciales/farmacología , Glutatión/metabolismo , Hipolipemiantes/farmacología , Riñón/metabolismo , Riñón/patología , Ácidos Linoleicos , Nefrosis/inducido químicamente , Oenothera biennis , Aceites de Plantas , Proteinuria , Distribución Aleatoria , Ratas , Ratas Sprague-Dawley , Valores de Referencia , Tiourea/uso terapéutico , Factores de Tiempo , Triglicéridos/sangre , Ácido gammalinolénico
15.
Crit Care Med ; 20(6): 823-30, 1992 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-1597038

RESUMEN

BACKGROUND AND METHODS: The protective effects of dimethylthiourea, a potent scavenger of hydroxy radical (.OH) and hydrogen peroxide, in experimental lung injury in large animals remain controversial. The present study was designed to determine whether dimethylthiourea can ameliorate the acute lung injury produced in dogs by phorbol myristate acetate. Six dogs were infused with dimethylthiourea (0.75 g/kg in saline) for 1.5 hrs, beginning 1 hr before an i.v. bolus injection of phorbol myristate acetate (17 micrograms/kg); six dogs received phorbol myristate acetate (17 micrograms/kg) alone; and six dogs were infused with saline alone. Hemodynamic changes, arterial oxygenation, and the development of lung edema were monitored for 4 hrs after phorbol myristate acetate injection to assess the extent of lung damage. RESULTS: As compared with the dogs that received phorbol myristate acetate alone, the edematous lung damage was significantly reduced in those dogs that received dimethylthiourea as well as phorbol myristate acetate. In the dimethylthiourea-treated dogs, the lung wet/dry weight ratios were smaller (p less than .01); protein concentrations in lung lavage fluid were lower (p less than .01); the decrease in PaO2 was significantly reduced (p less than .01); and there were significant reductions in the alveolar-arterial oxygen tension difference (P[A-a]O2) (p less than .01) and shunt (Qsp/Qt) (p less than .05). Also, dimethylthiourea significantly lowered the increased mean pulmonary arterial pressure levels during the second half of the experiment. CONCLUSIONS: These experimental data suggest that dimethylthiourea is capable of reducing the neutrophil-mediated lung injury produced by the release of hydroxy radical and/or hydrogen peroxide in dogs exposed to phorbol myristate acetate.


Asunto(s)
Pulmón/efectos de los fármacos , Acetato de Tetradecanoilforbol/toxicidad , Tiourea/análogos & derivados , Enfermedad Aguda , Animales , Análisis de los Gases de la Sangre , Perros , Evaluación Preclínica de Medicamentos , Femenino , Hemodinámica/efectos de los fármacos , Hemodinámica/fisiología , Pulmón/fisiopatología , Masculino , Edema Pulmonar/inducido químicamente , Edema Pulmonar/tratamiento farmacológico , Edema Pulmonar/fisiopatología , Distribución Aleatoria , Tiourea/uso terapéutico , Factores de Tiempo
16.
Yakugaku Zasshi ; 111(1): 51-8, 1991 Jan.
Artículo en Japonés | MEDLINE | ID: mdl-1905349

RESUMEN

The radiation protective mechanisms on skin injury induced by soft X-irradiation were investigated by use of various radiation protective agents such as sulfur compounds (MEA, MEG, thiourea), nucleic acid constitutional compounds (adenosine, inosine), antioxidative compounds (sesamol, ferulic acid, ascorbic acid), crude drugs (Rosae Fructus, Anemarrhenae Rhizoma, Trapae Fructus, Forsythiae Fructus, Aloe arborescens). Scavenge action of activated oxygen, inhibitory effect of lipid peroxidation, induction of antioxidative protein and protective effect against damage of deoxyribonucleic acid and superoxide dismutase by X-irradiation were evaluated as the radiation protective mechanisms, and relationship between these results and protective effect of skin injury induced by radiation was studied.


Asunto(s)
Medicamentos Herbarios Chinos/uso terapéutico , Traumatismos Experimentales por Radiación/tratamiento farmacológico , Piel/lesiones , Adenosina/farmacología , Adenosina/uso terapéutico , Animales , Benzodioxoles , Ácidos Cumáricos/farmacología , Ácidos Cumáricos/uso terapéutico , Medicamentos Herbarios Chinos/farmacología , Depuradores de Radicales Libres , Peroxidación de Lípido/efectos de los fármacos , Masculino , Ratones , Ácidos Nucleicos/metabolismo , Fenoles/farmacología , Fenoles/uso terapéutico , Traumatismos Experimentales por Radiación/metabolismo , Ratas , Ratas Endogámicas , Tiourea/farmacología , Tiourea/uso terapéutico , Timidina/farmacología , Timidina/uso terapéutico
17.
Stroke ; 20(4): 488-94, 1989 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-2467408

RESUMEN

Free radicals have been shown to play an important role in ischemia-reperfusion injury in several organ systems; however, the role of free radicals in central nervous system ischemia has been less well studied. Many potential free radical-generating systems exist. The primary products of these reactions, superoxide and hydrogen peroxide, may combine to produce hydroxyl radicals. Of the many potential sources of free radical generation, the enzyme xanthine oxidase has been shown to be important in ischemia in noncerebral tissue. We investigated the effect of the hydroxyl radical scavenger dimethylthiourea and the xanthine oxidase inhibitor allopurinol on infarct volume in a model of continuous partial ischemia. Male Sprague-Dawley rats were treated with dimethylthiourea or allopurinol before middle cerebral artery occlusion. Infarct volume was measured by triphenyltetrazolium chloride staining of brains removed 3 or 24 hours after occlusion. Stroke volume was reduced by 30% after dimethylthiourea treatment and by 32-35% after allopurinol treatment. At 24 hours after stroke, cortical tissue was more effectively protected than caudate tissue with both agents. Pretreatment with dimethylthiourea and allopurinol also significantly reduced cerebral edema formation and improved blood-brain barrier function as measured by fluorescein uptake. Our results imply that hydroxyl radicals are important in tissue injury secondary to partial cerebral ischemia and that xanthine oxidase may be the primary source of these radicals.


Asunto(s)
Alopurinol/uso terapéutico , Arteriopatías Oclusivas/complicaciones , Arterias Cerebrales , Infarto Cerebral/prevención & control , Tiourea/análogos & derivados , Alopurinol/administración & dosificación , Animales , Barrera Hematoencefálica/efectos de los fármacos , Química Encefálica , Infarto Cerebral/etiología , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos , Masculino , Ratas , Ratas Endogámicas , Coloración y Etiquetado , Volumen Sistólico/efectos de los fármacos , Tiourea/administración & dosificación , Tiourea/uso terapéutico , Factores de Tiempo
20.
Farmakol Toksikol ; 41(1): 101-4, 1978.
Artículo en Ruso | MEDLINE | ID: mdl-624380

RESUMEN

Following the action of extraordinary stimulants (hypoxic hypoxia, hypoxia+hyperoxia, hypodynamia+hyperthermy) animals demonstrate accumulation of malonic dialdehyde with a simultaneous fall of antiradical activity of the liver tissue. A preliminary introduction to rats of acetylene amines--1,4 bis (3-morpholinopropynyl) benzol 3,4,5-(morpholinopropynyl)-1-methylpyrazol and also of tocopherol antioxidant and gutumine antihypoxant averts activation of the lipids peroxidation processes. The inhibition of peroxidation with the studied agents is attended by stabilization of lyzosomal and mitochondrial membranes. Unsaturated amines prevent destruction of the organelles membranes provoked by the UV-irradiation and incubation at 37 degrees C (pH--4.7).


Asunto(s)
Amidinas/uso terapéutico , Aminas/uso terapéutico , Fiebre/metabolismo , Hipoxia/metabolismo , Metabolismo de los Lípidos , Hígado/metabolismo , Tiourea/análogos & derivados , Fosfatasa Ácida/efectos de la radiación , Alquinos/uso terapéutico , Altitud , Animales , Evaluación Preclínica de Medicamentos , Cinética , Lisosomas/enzimología , Oxidación-Reducción , Peróxidos/metabolismo , Ratas , Tiourea/uso terapéutico , Factores de Tiempo , Rayos Ultravioleta , Vitamina E/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA